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Iron-dependent degradation of iron-regulatory pro-
tein 2 (IRP2) is a key event for maintenance of an
appropriate intracellular concentration of iron. Al-
though FBXL5 (F box and leucine-rich repeat protein
5) is thought to mediate this degradation, the role of
FBXL5 in the control of iron homeostasis in vivo
has been poorly understood. We have now found
thatmice deficient in FBXL5 died in utero, associated
with excessive iron accumulation. This embryonic
mortality was prevented by additional ablation of
IRP2, suggesting that impaired IRP2 degradation is
primarily responsible for the death of Fbxl5/
mice. We also found that liver-specific deletion of
Fbxl5 resulted in deregulation of both hepatic and
systemic iron homeostasis, leading to the develop-
ment of steatohepatitis. The liver-specific mutant
mice died with acute liver failure when fed a high-
iron diet. Thus, our results uncover a major role for
FBXL5 in ensuring an appropriate supply of iron to
cells.
INTRODUCTION
Iron is an essential cofactor for many proteins that function in
oxygen transport, cellular respiration, or DNA synthesis (Rouault
and Tong, 2005), with iron deficiency resulting in cellular growth
arrest and death. Conversely, the chemical properties of iron
give rise to side reactions that damage macromolecules (Hentze
et al., 2010). Thus, excess ferrous iron reacts with hydrogen
peroxide or lipid peroxides to generate hydroxyl and lipid radi-
cals, respectively. These oxygen metabolites react readily with
biological molecules including proteins, lipids, and DNA. Given
that both iron deficiency and iron overload are deleterious to
cells, defects in iron acquisition at the cellular and systemic
levels lead to human disorders (De Domenico et al., 2008).
Thus, iron homeostasis is strictly controlled to ensure provision
of a proper amount of iron to cells.
The control of systemic iron homeostasis occurs through
regulation of iron acquisition (Andrews and Schmidt, 2007),Cell Megiven that iron loss occurs only through exfoliation and blood
loss. Plasma iron levels are determined predominantly by the
amount of duodenal iron absorption and by iron release from
macrophages that recycle iron from senescent red blood cells
(Wang and Pantopoulos, 2011). These iron fluxes are precisely
regulated by hepcidin, a small peptide hormone released from
the liver that is also known as Hamp1 or Leap1. Hepcidin nega-
tively regulates iron transport into plasma by controlling the
expression of an iron exporter, ferroportin (Nemeth et al.,
2004). Thus, systemic iron metabolism is maintained in balance
by the hepcidin-ferroportin regulatory system.
At the cellular level, iron homeostasis is regulated by coordina-
tion of iron uptake, storage, export, and utilization (Hentze et al.,
2010). Iron is imported into cells in the ferrous form and accumu-
lates as a cytosolic labile iron pool (LIP) that is essential for direct
incorporation of iron into proteins or for its transport into mito-
chondria, which constitute a major site of iron utilization. Ferrous
iron from the LIP that is not utilized for metalation reactions is
exported by ferroportin or stored in a redox-inactive form (ferric
iron) bound to ferritin, thereby preventing iron-mediated cell
damage. Thus, the size of the LIP is determined by the rates of
iron uptake, storage, export, and utilization, and these processes
must be strictly regulated to prevent deleterious iron deficiency
or excess.
The abundance of some proteins that contribute to deter-
mination of the size of the LIP is regulated at the posttranscrip-
tional level by iron-regulatory protein 1 (IRP1) and IRP2 (Muck-
enthaler et al., 2008). These RNA-binding proteins interact with
conserved cis-regulatory hairpin structures known as iron-
responsive elements (IREs) during iron-limiting conditions to
regulate the translation and stability of mRNAs that encode
proteins required for iron homeostasis. IRP1 (but not IRP2) is
a bifunctional protein: in the apo-IRP1 form, it binds to IREs
and thereby controls gene expression; however, it also assem-
bles to form a [4Fe-4S] cluster that does not bind IREs and
thereby becomes cytosolic aconitase (holo-IRP1) under iron-
sulfur cluster-replete conditions. Both apo-IRP1 and IRP2 inhibit
initiation of translation when they are bound to IREs in the 50
untranslated regions of mRNAs for the H or L chains of ferritin
(which mediate iron storage), for ferroportin (which mediates
iron export), or for aminolevulinic acid synthase 2 (Alas2, which
mediates iron utilization), whereas their binding to the IRE in
the 30 untranslated region of the mRNA for transferrin receptor
1 (TfR1, which mediates iron uptake) prevents its degradation.tabolism 14, 339–351, September 7, 2011 ª2011 Elsevier Inc. 339
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the LIP (ferrous iron) during iron-limiting conditions. In contrast,
under iron-replete conditions, IRPs are degraded by the protea-
some, leading to a decrease in the size of the cytosolic LIP. Thus,
iron-dependent degradation of IRPs in iron-replete cells is a key
event in the maintenance of an appropriate intracellular concen-
tration of iron.
An iron- and oxygen-regulated SCF-type ubiquitin ligase (E3),
SCFFBXL5, has been shown to contribute to iron-dependent
degradation of IRP1 and IRP2 (Salahudeen et al., 2009; Vashisht
et al., 2009). FBXL5 (F box and leucine-rich repeat protein 5) is
a member of the F box family of proteins that confer substrate
specificity on SCF-type ubiquitin ligases (Jin et al., 2004;
Nakayama and Nakayama, 2006). FBXL5 contains a unique
hemerythrin domain that is related to a family of iron- and
oxygen-binding proteins in bacteria and invertebrates. Direct
binding of iron to the hemerythrin domain stabilizes FBXL5,which
is unstable under iron-deficient conditions. Thus, such binding
results in the degradation of IRPs by the stabilized FBXL5
under iron-replete conditions. However, despite its integral role
in IRP degradation, the biological relevance of FBXL5 as well as
its effects on iron homeostasis have remained unknown.
We have now inactivated the mouse FBXL5 gene globally and
selectively. Our characterization of these FBXL5-deficient mice
has revealed that FBXL5 plays a pivotal role in the maintenance
of appropriate concentrations of intracellular iron and that it is
essential both for embryonic development and for normal post-
natal liver physiology. Loss of FBXL5 in mice induced apoptosis
as a result of unrestrained IRP activity, and consistent with this
finding, deletion of Irp2 in Fbxl5/ mice prevented their embry-
onic death. Our results indicate that the FBXL5-IRP2 axis is inte-
gral to iron homeostasis in vivo.
RESULTS
Loss of FBXL5 Results in Embryonic Mortality in Mice
To elucidate the physiological functions of FBXL5, we generated
mice deficient in this protein. The FBXL5 gene was disrupted in
mouse embryonic stem cells (ESCs) by replacement of exons
4 and 5, which encode the F box domain, with IRES-lacZ and
PGK-neo-poly(A)-loxP cassettes (see Figure S1 available online).
Mice heterozygous for the Fbxl5 mutant allele were healthy,
fertile, and phenotypically indistinguishable from wild-type litter-
mates. In contrast no homozygous mutants were detected
among 372 newborn animals generated from heterozygote
crosses, even though the ratio of wild-type to heterozygous
offspring was normal (Figure 1A). Thus, the mutation appeared
to be embryonic lethal in the homozygous state. Whole-mount
in situ hybridization analysis revealed that FBXL5 mRNA was
present throughout wild-type embryos from embryonic day (E)
7.5 to E8.5 but that it was localized predominantly in the brain
from E9.5 to E11.5 (Figure 1B). No hybridization signal was
detected in Fbxl5/ embryos (Figure 1C).
To determine the time at which the Fbxl5 mutation becomes
lethal, we examined embryos from Fbxl5+/ intercrosses at
various developmental stages (Figure 1A). Most Fbxl5/
embryos underwent resorption manifesting growth retardation
and massive hemorrhage at E8.5 and thereafter, although the
mutant embryos appeared normal at E7.5 (Figure 1D). Histo-340 Cell Metabolism 14, 339–351, September 7, 2011 ª2011 Elseviepathologic examination revealed that Fbxl5+/ and Fbxl5/
embryos were indistinguishable at E7.5, with each egg cylinder
consisting of three layers of tissue (ectoderm, mesoderm, and
visceral endoderm) (Figure 1E). However, Fbxl5/ embryos
manifested growth retardation and were inviable at E8.5.
Apoptotic cells with condensed nuclei as well as hemorrhage
in the region of the ectoplacental cone were typically observed
in the Fbxl5/ embryos. Thus, these results suggested that
FBXL5 is essential for early embryonic development.
Fatal Iron Accumulation in Fbxl5–/– Embryos
To explore the cause of the abnormal cell death observed in the
ectoplacental cone of Fbxl5/ embryos, we performed diami-
nobenzidine (DAB)-enhanced Perls staining and DAB-enhanced
Turnbull staining, which are specific for ferric and ferrous iron,
respectively (Meguro et al., 2003) (Figure 2A). Both Perls- and
Turnbull-positive iron deposits were observed in the ectoplacen-
tal cone of Fbxl5/ embryos at E8.5, suggesting that ferrous
iron accumulated in these embryos. Furthermore, ferrous iron
deposits were also observed in the extraembryonic visceral
endoderm of Fbxl5/ embryos at E7.5, before morphological
changes were apparent.
The extraembryonic visceral endoderm and the ectoplacental
cone function as an early placenta in maternoembryonic nutrient
transport before formation of the placenta proper (Cross et al.,
1994). Given that iron is supplied to the embryo through this early
placenta, we hypothesized that the loss of FBXL5 might result in
iron overload in the early placenta, leading to oxidative stress. A
marked increase in the abundance of cytoplasmic 4-hydroxy-2-
nonenal (4-HNE)-modified proteins, an indicator of oxidative
stress, was apparent as early as E7.5 in the extraembryonic
visceral endoderm of Fbxl5/ embryos, compared with that in
Fbxl5+/ embryos (Figure 2B). Although the TUNEL (terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling)
assay did not detect apoptotic cells at E7.5 (Figure S2A), several
apoptotic cells were apparent in the ectoplacental cone as well
as in the embryonic portion of Fbxl5/ embryos at E8.5 (Fig-
ure 2C). These results suggested that the loss of FBXL5 results
in iron overload, leading to oxidative stress and apoptosis, in
the early embryo.
To assess directly the growth capability of Fbxl5/ embryos
independent of placental function, we examined the outgrowth
of blastocysts in culture. All Fbxl5+/+, Fbxl5+/, and Fbxl5/
blastocysts hatched, attached to the culture dish, and produced
apparently normal trophoblast giant cells and an inner cell mass
under normal iron conditions (Figure S2B), suggesting that
Fbxl5/ blastocysts develop normally in the absence of iron
stress. However, under high-iron conditions, development of
both the trophectoderm and inner cell mass by Fbxl5/ blasto-
cysts was impaired, with this impairment being prevented by the
presence of the antioxidant N-acetyl-L-cysteine (NAC) (Fig-
ure 2D). Thus, these observations indicated that not only the
early placenta but also embryonic tissue is damaged by iron
overload and consequent oxidative stress in the absence of
FBXL5.
IRP Accumulation in FBXL5-Deficient Mice
Given that iron accumulation was observed in Fbxl5/
embryos, we hypothesized that upregulation of IRPs might ber Inc.
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Figure 1. Targeted Disruption of Fbxl5 Results in Embryonic Death
(A) Genotype frequencies for total embryos and live offspring produced from Fbxl5+/mouse intercrosses. Numbers in parentheses indicate resorbed embryos.
(B) Whole-mount in situ hybridization of C57BL/6 embryos at E7.5, E8.5, E9.5, and E11.5 with a riboprobe specific for FBXL5 mRNA. Scale bars, 500 mm.
(C) Whole-mount in situ hybridization of Fbxl5+/+ and Fbxl5/ embryos at E8.5 with an FBXL5 riboprobe. Scale bars, 500 mm.
(D) Gross appearance of Fbxl5+/+ versus Fbxl5/ embryos at E7.5, E8.5, and E9.5. EP, ectoplacental cone; EX, extraembryonic portion; EM, embryonic portion;
hf, headfold; al, allantois; ht, heart. Scale bars, 500 mm.
(E) Histopathology of Fbxl5/ embryos. The development of Fbxl5+/ and Fbxl5/ embryos is shown at E7.5 and E8.5. The boxed regions in the upper panels are
shown at highermagnification in the lower panels. Apoptotic cells with condensed nuclei (arrowheads) as well as hemorrhage and fibrin (asterisk) in the area of the
ectoplacental cone are indicated. ec, ectoderm; me, mesoderm; pe, parietal endoderm; ve, visceral endoderm; so, somites. Scale bars, 100 mm. See also
Figure S1.
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Figure 2. Fatal Iron Accumulation and Oxidative Stress in Fbxl5–/– Embryos
(A) DAB-enhanced Perls staining (top panels) and DAB-enhanced Turnbull staining (bottom panels) of Fbxl5+/ (E7.5) and Fbxl5/ (E7.5 and E8.5) embryos. The
boxed regions in the upper panels of each set are shown at higher magnification in the lower panels. Brown staining indicates iron accumulation in the extra-
embryonic visceral endoderm (E7.5) or ectoplacental cone (E8.5) of Fbxl5/ embryos (arrows). Scale bars, 100 mm.
(B) Sections of Fbxl5+/ and Fbxl5/ embryos at E7.5 were subjected to immunohistochemical staining with antibodies to 4-HNE. Arrowheads indicate an
increased staining intensity for 4-HNE-modified proteins in the extraembryonic visceral endoderm of the Fbxl5/ embryo. Scale bar, 50 mm.
(C) Sections of Fbxl5+/ and Fbxl5/ embryos at E8.5 were subjected to the TUNEL assay. Higher-magnification views of the ectoplacental cone (a) and
embryonic portion (b) of the Fbxl5/ embryo are also shown. Scale bars, 100 mm.
(D) Blastocysts from Fbxl5+/mouse intercrosses were cultured in the absence or presence of ferric ammonium citrate (FAC, 50 mg/ml) or NAC (1 mM) for 5 days
in vitro. The development of Fbxl5+/ and Fbxl5/ blastocysts was examined at E8.5. icm, inner cell mass; tr, trophectoderm. Scale bars, 100 mm. See also
Figure S2.
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Figure 3. Accumulation of IRPs in FBXL5-Deficient Mice
(A) RT and real-time PCR analysis of TfR1 mRNA in littermate embryos of Fbxl5+/ mouse intercrosses at E7.5. Normalized data are expressed relative to the
corresponding value for a control Fbxl5+/+ embryo and are mean ± SEM from three independent experiments. *p < 0.03 (Student’s t test).
(B) Sections of Fbxl5+/ and Fbxl5/ embryos at E7.5 were subjected to immunohistofluorescence analysis with antibodies to TfR1. The boxed regions in the
upper panels are shown at higher magnification in the lower panels. Arrows indicate an increased staining intensity for TfR1 in the extraembryonic mesoderm of
the Fbxl5/ embryo. Scale bars, 50 mm.
(C) Fbxl5+/+ or Fbxl5D/DMEFs were incubated for 16 hr in the absence or presence of FAC (100 mg/ml) or 100 mM of the ferric-iron chelator desferrioxamine (DFO)
and were then subjected to immunoblot (IB) analysis with antibodies to the indicated proteins. The asterisk indicates a nonspecific band.
(D) Immunoblot analysis of IRP1 and IRP2 in cells exposed to iron. Fbxl5+/+ or Fbxl5D/DMEFs were incubated for 16 hr with 100 mMDFO and then exposed to FAC
(50 mg/ml) for the indicated times.
(E) Total nonheme iron levels in cytosolic andmitochondrial fractions prepared from Fbxl5+/+ or Fbxl5D/DMEFs that had been exposed to FAC (100 mg/ml) for 48 hr.
Data are mean ± SD from three independent experiments. **p < 0.01 (Student’s t test). See also Figure S3.
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weexamined theabundanceof TfR1mRNA,adownstreamtarget
of IRPs, in the mutant embryos. The amount of TfR1 mRNA was
markedly increased in Fbxl5/ embryos (Figure 3A). Immuno-Cell Mestaining also revealed that TfR1 accumulated in the extra-
embryonic mesoderm of Fbxl5/ embryos at E7.5 (Figure 3B).
Thus, these results suggested that IRP activity is increased, re-
sulting in deregulation of IRP target genes, in Fbxl5/ embryos.tabolism 14, 339–351, September 7, 2011 ª2011 Elsevier Inc. 343
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Figure 4. Prevention of Embryonic Mortality in FBXL5-Deficient Mice by Ablation of IRP2
(A) Gross appearance of Fbxl5+/+Irp2+/+ versus Fbxl5/Irp2/ littermates at 5 weeks of age.
(B) Genotype frequencies of 4-week-old mice produced from Fbxl5+/Irp2+/ mouse intercrosses.
(C) Box plot with whiskers from minimum to maximum body weight in Fbxl5+/+Irp2+/+ (n = 22), Fbxl5+/+Irp2/ (n = 10), Fbxl5+/Irp2/ (n = 26), and
Fbxl5/Irp2/ (n = 15) mice at 4 weeks of age. n.s., not significant (p > 0.05, Student’s t test).
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FBXL5-IRP2 Axis and Control of Iron MetabolismThe early embryonic mortality of the Fbxl5/mutant impeded
in-depth analysis of the role of FBXL5 in iron homeostasis. To
overcome this obstacle, we generated mice in which Fbxl5 is
conditionally ablated in a tissue-specific manner. To this end,
we first produced mice harboring a ‘‘floxed’’ allele of Fbxl5, in
which exons 4 and 5 are flanked by loxP sites (Figures S3A–S3C).
Mice homozygous for the floxed Fbxl5 allele (Fbxl5F/F mice) had
no apparent defects, indicating that the allele is fully functional.
To investigate whether iron-dependent degradation of IRPs is
impaired in FBXL5-deficient mice, we prepared mouse embry-
onic fibroblasts (MEFs) from Fbxl5+/+ and Fbxl5F/F embryos at
E13.5 and subsequently infected these cells with a retroviral
vector encoding Cre recombinase. We confirmed that almost
all floxed alleles were deleted by Cre recombinase in the MEFs
from Fbxl5F/F embryos, giving rise to Fbxl5D/DMEFs (Figure S3D).
Immunoblot analysis revealed that the abundance of IRP1 and
IRP2 was increased in Fbxl5D/D MEFs, whereas that of the other
potential substrate of FBXL5, p150Glued (Zhang et al., 2007), was
not (Figure 3C). Such IRP accumulation was apparent even
under iron-replete conditions. Consistent with this finding, the
expression of proteins encoded by mRNA targets of IRPs was
also deregulated: thus, the abundance of TfR1 (which mediates
iron uptake) was increased, whereas that of ferritin (which
mediates iron storage) was decreased likely as a result of IRP-
mediated translational suppression (Figure 3C). However, the
transcription of ferritin genes is also regulated by oxidative stress
through an antioxidant-responsive element (ARE) in the 50 region
(MacKenzie et al., 2008). Indeed, the expression of ferritin was
markedly increased at both mRNA (Figure S3E) and protein
(Figure 3C) levels in Fbxl5D/DMEFs under the iron-replete condi-
tion, suggesting that transcriptional activation of ferritin genes
by oxidative stress dominates the translational suppression
mediated by constitutively active IRPs. Furthermore, the iron-
dependent degradation of IRP2 was impaired in Fbxl5D/D MEFs
(Figure 3D). Although the abundance of IRP1 in Fbxl5D/D
MEFs was markedly increased compared with that in Fbxl5+/+
MEFs, the half-life of this protein was long even in iron-replete
Fbxl5+/+ MEFs (Figure 3D), probably reflecting the fact that
most IRP1s exist in the holo-IRP1 form, which is resistant to
degradation in iron-replete cells (Recalcati et al., 2006). These
results suggested that IRPs accumulate, resulting in an increase
in total IRP activity, in FBXL5-deficient embryos and MEFs in
amanner independent of iron conditions, leading to deregulation
of IRP targets.
We next examined how such IRP hyperactivation affects
cellular iron homeostasis. The levels of iron in isolated cytosolic
and mitochondrial fractions (Figure S3F) were greater for
Fbxl5D/D MEFs than for Fbxl5+/+ MEFs (Figure 3E), suggesting
that the accumulated IRPs promote iron loading in the cytosol
andmitochondria, leading to oxidative stress, in the former cells.
Thus, collectively, our observations suggested that the abun-
dance and activity of IRPs are increased in a manner indepen-(D) Nonheme iron content of the liver and spleen of Fbxl5+/+Irp2+/+ (n = 8), Fbxl5+
9–13 weeks of age. Data are mean ± SD. **p < 0.01 (Student’s t test).
(E) Immunoblot analysis of extracts of the cerebrum, liver, and kidney of 11-week-o
animals were examined for each genotype.
(F) Primary cultured MEFs of the indicated genotypes were incubated for 16 hr i
subjected to immunoblot analysis with antibodies to the indicated proteins. The
Cell Medent of iron conditions, leading to increased oxidative stress
and embryonic death as a result of iron overload, in FBXL5-defi-
cient mice.
Fbxl5–/–Irp2–/– Mice Develop Normally
To test our hypothesis that IRP accumulation is responsible for
the early embryonic death of Fbxl5/ mice, we examined
whether additional ablation of IRP2, which dominates control
of iron homeostasis in vivo (Meyron-Holtz et al., 2004b), pre-
vented the embryonic mortality of these animals. Whereas
most Fbxl5/ mice died in utero at E8.5, Fbxl5/Irp2/ mice
developed normally and were fertile (Figures 4A and 4B).
Fbxl5/Irp2/ mice were macroscopically indistinguishable
from wild-type littermates and grew normally (Figure 4C).
Iron metabolism in Fbxl5/Irp2/ mice appeared almost
identical to that in Irp2/ mice, with some exceptions. Irp2/
mice manifest mild microcytic anemia and an abnormal distribu-
tion of iron within the body, including iron accumulation in
the liver and a reduced iron level in the spleen (Cooperman
et al., 2005; Galy et al., 2005). The hematocrit and serum concen-
tration of hemoglobin were significantly reduced in Irp2/ mice
in association with a normal erythrocyte count and a lower
mean cell volume (Table 1). The hematologic parameters of
Fbxl5/Irp2/ mice were indistinguishable from those of
Irp2/ mice. However, the serum iron concentration as well as
transferrin saturation were increased in Fbxl5/Irp2/ mice,
whereas these parameters did not differ between Irp2/ and
wild-type mice (Table 1). Although the precise mechanism
underlying these paradoxical increases remains unknown, these
results suggest that the microcytosis in Fbxl5/Irp2/ mice is
not attributable to systemic iron deficiency. We also measured
organ nonheme iron content and found that it was increased in
the liver and decreased in the spleen of Irp2/mice, consistent
with previous observations, whereas the liver iron content of
Fbxl5/Irp2/ mice was significantly decreased compared
with that of Irp2/ mice (Figure 4D). Immunoblot analysis re-
vealed that the abundance of ferroportin was not significantly
changed in the liver of Fbxl5/Irp2/ mice (Figure S4A). The
expression of the iron-storage protein ferritin was increased in
the cerebrum, liver, and kidney of Irp2/ mice (Figure 4E).
However, the abundance of ferritin in the liver of Fbxl5/Irp2/
mice was decreased compared with that in Irp2/mice, mirror-
ing the decrease in iron content. An electrophoretic mobility
shift assay (EMSA) revealed that the IRE-binding activity of
IRP1 in the liver of Fbxl5/Irp2/ mice was increased by
20% compared with that in Irp2/ mice (Figures S4B and
S4C), which may account for the decreased ferritin level.
We generated Fbxl5/Irp2/ MEFs and analyzed the
response of iron-related proteins in these cells to changes in
iron availability. The abundance of IRP1 in Fbxl5/Irp2/
MEFs was increased compared with that in Irp2/ MEFs,
and this difference was associated with a slight increase in/+Irp2/ (n = 8), Fbxl5+/Irp2/ (n = 10), and Fbxl5/Irp2/ (n = 12) mice at
ldmice of the indicated genotypes with antibodies to ferritin and toHsp90. Two
n the absence or presence of FAC (100 mg/ml) or 100 mM DFO and were then
asterisk indicates a nonspecific band. See also Figure S4.
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Table 1. Hematologic and Serum Iron Parameters of Fbxl5–/–Irp2–/– Mice
Hematologic Parameters
Parameter Fbxl5+/+Irp2+/+ (n = 11) Fbxl5+/+Irp2/ (n = 8) Fbxl5+/Irp2/ (n = 11) Fbxl5/Irp2/ (n = 15)
RBC count (104/ml) 1000 ± 37.8 952 ± 60.1 998 ± 55.4 985 ± 40.0
MCV (fl) 52.4 ± 0.6 49.3 ± 0.7a 48.9 ± 1.1a 48.7 ± 1.0a
Hematocrit (%) 52.4 ± 2.2 47.0 ± 3.2a 48.6 ± 2.5a 48.0 ± 1.9a
Serum hemoglobin (g/dl) 15.9 ± 0.7 13.7 ± 0.9a 14.3 ± 0.7a 14.0 ± 0.5a
MCH (pg) 15.9 ± 0.2 14.4 ± 0.4a 14.3 ± 0.5a 14.2 ± 0.3a
MCHC (g/dl) 30.3 ± 0.3 29.3 ± 0.5a 29.3 ± 0.5a 29.2 ± 0.5a
Serum Iron Parameters
Parameter Fbxl5+/+Irp2+/+ (n = 6) Fbxl5+/+Irp2/ (n = 6) Fbxl5+/Irp2/ (n = 6) Fbxl5/Irp2/ (n = 8)
TIBC (mg/dl) 366 ± 26. 4 359 ± 44.4 398 ± 36.9 334 ± 36.6
Iron (mg/dl) 150 ± 33.1 152 ± 32.6 163 ± 30.7 209 ± 33.5a
Transferrin saturation (%) 41.4 ± 11.1 42.5 ± 8.8 41.0 ± 8.8 63.9 ± 15.2a
Data are mean ± SD for the indicated numbers of 9- to 13-week-old mice. Transferrin saturation was calculated from measured serum iron and TIBC.
RBC, red blood cell; MCV, mean cell volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; TIBC, total
iron-binding capacity.
a p < 0.01 versus Fbxl5+/+Irp2+/+ mice (Student’s t test).
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These observations suggested that IRP1 activity was slightly
increased in Fbxl5/Irp2/ mice. Thus, we concluded that
the increased activity of IRP1 in Fbxl5/Irp2/mice attenuated
the increased hepatic levels of iron and ferritin apparent in
Irp2/ mice.
Liver-Specific Ablation of Fbxl5
To study the function of FBXL5 in adult mouse tissues, we next
examined the consequences of FBXL5 deficiency in the liver,
which plays a central role in systemic iron homeostasis. To
ablate Fbxl5 in the liver, we crossed Fbxl5F/F mice with mice
harboring a Cre transgene under the control of the promoter
for the albumin gene (Alb-Cre mice). We confirmed that almost
all floxed alleles were inactivated by Cre recombinase in the liver
of Alb-Cre/Fbxl5F/F mice, as revealed by a corresponding
decrease in the amount of FBXL5 mRNA (Figure S5A). Alb-Cre/
Fbxl5F/F mice were viable, but the liver of these animals was
lighter in color compared with that of their Alb-Cre/Fbxl5F/+ litter-
mates (Figure 5A). Histological analysis revealed that the nuclei
of cells in the liver of Alb-Cre/Fbxl5F/F mice remained centrally
located, whereas the corresponding cytoplasm was only weakly
eosinophilic and contained numerous microvesicular vacuoles
(Figures 5B and 5C). Lobular infiltration of inflammatory cells
such as lymphocytes and neutrophils was also observed in the
liver of Alb-Cre/Fbxl5F/F mice (Figure 5D), indicative of hepatic
inflammation. However, serum chemistry parameters associ-
ated with liver damage did not differ between the mutant and
control mice under normal fed conditions (Table S1), indicating
that the hepatic inflammation in the mutant animals is mild. Oil
red O staining revealed deposition of multiple small lipid droplets
with an undisplaced nucleus in liver cells of the mutant mice
(Figures 5E and 5F), a characteristic of liver damage associated
with impaired mitochondrial function (Burt, 2001). Consistent
with mitochondrial dysfunction, ATP levels of Fbxl5D/D MEFs
under basal conditions were reduced compared with those of
Fbxl5+/+ MEFs, and this reduction was further enhanced under346 Cell Metabolism 14, 339–351, September 7, 2011 ª2011 Elseviehigh-iron conditions (Figure S5B). Moreover, electron micros-
copy revealed mitochondriopathy associated with small lipid
droplets in FBXL5-deficient hepatocytes; the mitochondria
were swollen, with a hypodense matrix suggestive of mitochon-
drial injury (Figures 5G–5J).
We next examined iron metabolism in Alb-Cre/Fbxl5F/F mice.
DAB-enhanced Perls and Turnbull staining revealed the accu-
mulation of ferrous iron in hepatocytes of Alb-Cre/Fbxl5F/F
mice (Figures 5K–5N). Immunoblot analysis showed that IRP2
also accumulated in the liver of these mice (Figure 5O). The
abundance of IRP1 was also increased in the liver of Alb-Cre/
Fbxl5F/F mice, but the extent of this change was much less
pronounced than was that observed in Fbxl5D/D MEFs—prob-
ably because the iron-sulfur cluster of IRP1 is readily destabi-
lized by exposure to oxygen in cultured cells, leading to conver-
sion of holo-IRP1 to the IRE-binding, apo-IRP1 form. Given the
predominance of holo-IRP1 and the conversion of only a small
fraction of this form to apo-IRP1 in mouse tissues (Meyron-
Holtz et al., 2004a), the amount of apo-IRP1 in the liver of
Alb-Cre/Fbxl5F/F mice may be masked by the more abundant
holo-IRP1, which is not degraded by FBXL5 (Salahudeen
et al., 2009; Vashisht et al., 2009). The upregulation of IRP2 in
the liver of Alb-Cre/Fbxl5F/F mice was also associated with
increased TfR1 expression (Figure 5O) and iron accumulation
specifically in the liver (Figure 5P). The abundance of ferritin in
the liver of Alb-Cre/Fbxl5F/F mice was paradoxically also
increased despite the accumulation of IRP2 (Figure 5O). The
amount of mRNA for the L chain of ferritin in the liver was
greater for Alb-Cre/Fbxl5F/F mice than for Fbxl5F/F littermates,
and this increase was greatly enhanced under conditions of
oxidative stress induced by feeding the animals a high-iron
diet (Figure S5C). Given that iron loss induces degradation of
ferritin by the proteasome (De Domenico et al., 2006), both tran-
scriptional and posttranslational mechanisms may contribute to
upregulation of ferritin that dominates over IRP-mediated trans-
lational suppression of ferritin mRNA in the liver of Alb-Cre/
Fbxl5F/F mice.r Inc.
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Figure 5. Hepatocyte-Specific Ablation of
Fbxl5 Results in Iron Accumulation and
Steatohepatitis
(A) Gross appearance of the liver of Alb-Cre/
Fbxl5F/+ andAlb-Cre/Fbxl5F/Fmouse littermates at
32 weeks of age. Scale bar, 10 mm.
(B–F) Histological analysis of the liver of 16- to
32-week-old Alb-Cre/Fbxl5F/F mice (C, D, and F)
compared with that of control Alb-Cre/Fbxl5F/+
littermates (B and E). (B–D) Hematoxylin and
eosin staining. Arrows indicate numerous micro-
vesicular vacuoles, and the arrowhead indicates
lobular infiltration of inflammatory cells. (E and F)
Oil red O staining. The inset in (F) shows a corre-
sponding higher-magnification view. Asterisks
indicate cell nuclei. Scale bars, 20 mm.
(G–J) Electron microscopy of the liver of 12-week-
old Alb-Cre/Fbxl5F/F mice (H and J) compared
with that of control Alb-Cre/Fbxl5F/+ littermates
(G and I). Arrows indicate numerous pale and
swollen mitochondria, and the arrowheads indi-
cate numerous lipid droplets. Scale bars, 2 mm.
(K–N) DAB-enhanced Perls staining (K and L) and
DAB-enhanced Turnbull staining (M and N) of the
liver of 16- to 32-week-old Alb-Cre/Fbxl5F/F mice
(L and N) compared with that of control Alb-Cre/
Fbxl5F/+ littermates (K and M). Scale bars, 20 mm.
(O) Immunoblot analysis of liver extracts from
15-week-old mice of the indicated genotypes with
antibodies to the indicated proteins. The asterisk
indicates a nonspecific band.
(P) Nonheme iron content of the indicated organs
of Alb-Cre/Fbxl5F/+ (n = 4) and Alb-Cre/Fbxl5F/F
(n = 8) mice at 16–32 weeks of age. Data are
mean ± SD. n.s., not significant. **p < 0.01
(Student’s t test). See also Figure S5 and Table S1.
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We next asked how liver-specific deletion of Fbxl5 affects
systemic iron homeostasis. Serum iron levels (Figure 6A) as
well as transferrin saturation (Figure 6B) were significantly in-
creased in Alb-Cre/Fbxl5F/F mice, whereas hematologic para-
meters were not changed (Table S1). These results suggested
that, inappropriately for their overall iron status, thesemicemight
express low levels of hepcidin, the negative regulator of iron
transport into plasma. The abundance of hepcidin mRNA in the
liver was indeed significantly smaller for Alb-Cre/Fbxl5F/F mice
than for Fbxl5F/F littermates (Figure 6C), and such a difference
was also apparent when hepcidin gene expression was
increased by feeding the animals a high-iron diet.
To elucidate the mechanism underlying the downregulation of
hepcidin mRNA in the liver of Alb-Cre/Fbxl5F/F mice, we exam-Cell Metabolism 14, 339–351, Sined bone morphogenetic protein (BMP)
signaling, which is the predominant
regulator of hepcidin gene transcription
(Hentze et al., 2010). Whereas the hepatic
abundance of Hfe2 mRNA was unaf-
fected (Figure S6A), that of BMP6
mRNA was smaller for Alb-Cre/Fbxl5F/F
mice than for Fbxl5F/F littermates, and
this difference was also apparent when
Bmp6 expression was increased byfeeding the animals a high-iron diet (Figure S6B). We also exam-
ined receptor-activated Smad phosphorylation and found that
the phosphorylation level of Smad1, Smad5, and Smad8
(Smad1/5/8) was decreased in the liver of Alb-Cre/Fbxl5F/F
mice (Figure 5O). The amounts of mRNAs for suppressors of
hepcidin gene transcription such as Smad6, Smad7, and trans-
membrane serine protease 6 (Tmprss6) were not increased in the
liver of Alb-Cre/Fbxl5F/F mice, but rather were paradoxically
decreased (Figure S6C). Increased iron did not activate Smad7
transcription in the liver ofAlb-Cre/Fbxl5F/Fmice, likely as a result
of decreased BMP signaling (Kautz et al., 2008). Collectively,
these findings indicated that BMP signaling in the liver of Alb-
Cre/Fbxl5F/F mice is decreased as a result of the reduced
expression of Bmp6, and they suggested that the decrease in
Bmp6 expression is likely responsible for downregulation ofeptember 7, 2011 ª2011 Elsevier Inc. 347
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Figure 6. Fatal Liver Failure in Alb-Cre/Fbxl5F/F Mice Fed a High-Iron Diet
(A) Serum nonheme iron concentration in Fbxl5F/F (n = 4), Alb-Cre/Fbxl5F/+ (n = 6), and Alb-Cre/Fbxl5F/F (n = 7) mice at 16–32 weeks of age. Data are mean ± SD.
n.s., not significant. **p < 0.01 (Student’s t test).
(B) Serum transferrin saturation in Fbxl5F/F (n = 3), Alb-Cre/Fbxl5F/+ (n = 6), and Alb-Cre/Fbxl5F/F (n = 8) mice at 16–32 weeks of age. Transferrin saturation was
calculated from measured total (TIBC) and unsaturated (UIBC) iron-binding capacities. Data are mean ± SD. **p < 0.01 (Student’s t test).
(C) RT and real-time PCR analysis of hepcidinmRNA in the liver of 16-week-oldmice of the indicated genotypes fed a normal diet or exposed to a high-iron diet for
1 day. Normalized data are expressed relative to the corresponding value for control mice (Fbxl5F/F mice fed a normal diet) and are mean ± SEM (n = 3 mice per
group). **p < 0.01 (Student’s t test).
(D) Kaplan-Meier survival curves for 6-week-old mice of the indicated genotypes after the start of a high-iron diet.
(E) Gross appearance of the liver of 6-week-old Alb-Cre/Fbxl5F/+ and Alb-Cre/Fbxl5F/F littermates at 1 day after the start of a high-iron diet. Arrowheads indicate
bleeding. Scale bar, 10 mm.
(F) Serum AST, ALT, and LDH activities in 6-week-old Alb-Cre/Fbxl5F/+ (n = 6) and Alb-Cre/Fbxl5F/F (n = 4) mice at 1 day after the start of a high-iron diet. The
results are plotted on a logarithmic ordinate, and horizontal lines indicate mean values. **p < 0.01 (Student’s t test).
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FBXL5-IRP2 Axis and Control of Iron Metabolismhepcidin in the liver of these mice. They further suggested that
liver-specific ablation of FBXL5 results in systemic iron overload
as a result of a reduced level of hepcidin secretion from the liver.
Fatal Liver Failure in Alb-Cre/Fbxl5F/F Mice Fed
a High-Iron Diet
Given that hepcidin expression was downregulated in Alb-Cre/
Fbxl5F/F mice, we next examined the effect of iron overload in
these animals fed a high-iron diet. Whereas all control mice
remained alive, most Alb-Cre/Fbxl5F/F mice died within 1 day,
and the rest ate very little of the diet and lost weight, finally dying
of starvation within 2 weeks (Figure 6D). Macroscopic examina-
tion of the Alb-Cre/Fbxl5F/F mice revealed prominent hemor-
rhage on the surface of the fatty liver (Figure 6E). Both
prothrombin time (PT) and activated partial thromboplastin
time (APTT) were significantly increased for Alb-Cre/Fbxl5F/F
mice on the high-iron diet compared with those for Fbxl5F/F
mice (Figure S6D), suggestive of a severe coagulopathy in the
former animals. Serum levels of hepatic enzymes such as aspar-
tate aminotransferase (AST), alanine aminotransferase (ALT),
and lactate dehydrogenase (LDH) were also increased 100-
fold in these animals (Figure 6F), suggestive of an acute progres-
sive destruction of hepatocytes. Changes in biliary tract
enzymes were smaller than those in hepatic enzymes (Table
S2). Histological analysis revealed massive cell death, predomi-
nantly in the area around portal veins, in the FBXL5-deficient liver
(Figures 6G and 6H). DAB-enhanced Perls or Turnbull staining
also revealed the accumulation of ferrous iron in the hepatocytes
of Alb-Cre/Fbxl5F/F mice (Figures 6I–6L), whereas detection of
4-HNE-modified proteins revealed a marked increase in oxida-
tive stress (Figures 6M and 6N). TUNEL-positive cells were
also observed among hepatocytes of Alb-Cre/Fbxl5F/F mice
(Figures 6O and 6P). Furthermore, oxidative stress and cell death
in the liver were markedly attenuated by the addition of NAC to
the drinking water of Alb-Cre/Fbxl5F/F mice fed the high-iron
diet (Figure S6E). On the other hand, Irp2/ mice did not die
when fed a high-iron diet (n = 6, data not shown), probably
because the accumulation of ferrous iron was much less
pronounced than was that of ferric iron in these animals (Fig-
ure S6F). Given that the high-iron diet had little effect on the
iron content of other organs of Alb-Cre/Fbxl5F/F mice (data not
shown), these results indicated that Alb-Cre/Fbxl5F/F mice fed
such a diet died of acute liver failure resulting from iron excess.
Collectively, our observations implicate FBXL5 in the regulation
of iron homeostasis both at the systemic level and in the liver.
DISCUSSION
We have shown that the loss of FBXL5 results in upregulation of
IRP expression and activity, leading to fatal damage in embryos
or the adult liver due to the excessive accumulation of ferrous
iron. Our genetic evidence suggests that IRP2 is the major target
of the SCFFBXL5 E3 ligase. Our findings further indicate that
FBXL5 plays a central role in the maintenance of appropriate(G–P) Histological analysis of the liver of 6-week-old Alb-Cre/Fbxl5F/F mice (H, J,
after the start of a high-iron diet. Hematoxylin and eosin staining is shown in (G)
Turnbull staining is shown in (K) and (L), immunohistochemical staining with antib
(P). Scale bars, 100 mm. See also Figure S6 and Table S2.
Cell Meconcentrations of intracellular iron and is essential for embryonic
development as well as for normal postnatal liver physiology in
mice.
Regulation of IRP activity is essential for cells to maintain an
appropriate cytosolic LIP, thereby avoiding deleterious iron defi-
ciency and preventing iron excess. FBXL5 recognizes both IRP1
and IRP2 and promotes their degradation in an iron-dependent
manner. Our results now indicate that iron-dependent degrada-
tion of IRPs mediated by FBXL5 is pivotal for regulation of
their activity as well as for iron homeostasis in mice. FBXL5
also senses intracellular iron through direct iron binding to its
hemerythrin domain, resulting in FBXL5 stabilization (Sala-
hudeen et al., 2009; Vashisht et al., 2009). Thus, FBXL5 acts as
a sensor of the cytosolic LIP that negatively regulates this pool
through degradation of IRPs.
Maintenance of the cytosolic LIP at an appropriate level
is crucial, especially in cells exposed to iron overload. We
found that Fbxl5/ embryos die manifesting iron accumulation
in the early placenta, and that Fbxl5/ blastocysts do not
survive under iron-replete conditions. These results suggest
that FBXL5 is a key regulator that confers resistance to stress
resulting from iron overload. During embryogenesis, FBXL5
plays an essential role in the early placental regions. Given that
mice lacking the iron-exporting protein ferroportin, which trans-
fers iron from the extraembryonic visceral endoderm (early
placenta) into the embryo, die in utero (Donovan et al., 2005),
these early placental regions appear to be essential for iron
delivery to embryos, and they thereby need to endure stress
attributable to iron overload. FBXL5 appears to protect these
iron-transferring cells from damage due to excess iron.
FBXL5 also plays an essential role in normal postnatal liver
physiology by preventing systemic iron overload. Hereditary
hemochromatosis is a genetic disorder that leads to iron over-
load in the liver and other organs. Complications of this disease
include liver cirrhosis, cancer, diabetes, and heart failure. To
date, hereditary hemochromatosis has been attributed to
defects in five genes, four of which give rise to recessive disor-
ders (De Domenico et al., 2008). All recessive forms of the
disease are associated with molecular defects in hepatocytes
and are caused by inappropriately low levels of hepcidin expres-
sion. We have now shown that liver-specific ablation of FBXL5
results in downregulation of hepcidin expression and conse-
quent systemic iron overload. Therefore, hepatic expression of
FBXL5 might also be a determinant of iron overload disorders.
Iron overload status in FBXL5-deficient mice differs substan-
tially from that in other mice showing simple systemic iron
overload in terms of the valence of the accumulating iron
(Fe2+ or Fe3+). FBXL5-deficient mice manifest accumulation of
dangerous ferrous iron (Fe2+), whereas many other animal
models such as mice deficient in Hfe1 (Zhou et al., 1998), Hfe2
(Niederkofler et al., 2005), or hepcidin (Lesbordes-Brion et al.,
2006) exhibit accumulation of ferric iron (Fe3+) in the liver as
a result of defective hepcidin production. This point is key to
understanding iron metabolism in Alb-Cre/Fbxl5F/F mice, whichL, N, and P) and control Alb-Cre/Fbxl5F/+ littermates (G, I, K, M, and O) at 1 day
and (H), DAB-enhanced Perls staining is shown in (I) and (J), DAB-enhanced
odies to 4-HNE is shown in (M) and (N), and TUNEL staining is shown in (O) and
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load: the hepcidin-dependent intestinal barrier against iron
hyperabsorption, and the FBXL5-dependent intracellular barrier
against an inappropriate increase in the LIP. The aforementioned
other mutant mice retain the latter barrier, which minimizes an
inappropriate increase in the LIP. Thus, hepatic FBXL5 defi-
ciency gives rise to iron poisoning that is more severe than that
that results from simple systemic iron overload due to dietary
iron excess.
Hepatic iron overload is a pathophysiologic feature of nonal-
coholic steatohepatitis (NASH), chronic liver disease associated
with hepatitis C virus infection, and hepatocellular carcinoma
(Sorrentino et al., 2009). Excess ferrous iron generates hydroxyl
radicals that give rise to chronic inflammation, DNA damage,
genetic instability, and tumorigenesis as a result of oxidative
stress. Although iron accumulation itself may not initiate chronic
liver disease, it has a detrimental effect on disease progression.
We have now shown that liver-specific ablation of FBXL5 results
in an increased hepatic iron content, systemic iron overload, and
acute fatal liver failure in the presence of dietary iron overload.
Alb-Cre/Fbxl5F/F mice develop steatosis and inflammation of
the liver, reminiscent of human NASH, likely as a result of mito-
chondrial damage. Increased serum iron levels might worsen
the liver damage in Alb-Cre/Fbxl5F/F mice. Thus, we speculate
that a reduced level of FBXL5 expression in the human liver
might give rise to a vicious cycle of liver damage and contribute
to the progression of chronic inflammation and liver cancer.EXPERIMENTAL PROCEDURES
Generation of Fbxl5–/– and Fbxl5–/–Irp2–/– Mice
The targeting vector for Fbxl5was constructed by replacement of a 3.1 kb frag-
ment of genomic DNA containing exons 4 and 5 of Fbxl5 with IRES-lacZ and
PGK-neo-poly(A)-loxP cassettes. A diphtheria toxin A (DT-A) cassette was
ligated at the 30 end of the targeting construct. Maintenance, transfection,
and selection of mouse ESCs were performed as described previously
(Nakayama et al., 1996). Mutant ESCs were microinjected into C57BL/6
blastocysts, and resulting chimeraswerematedwith C57BL/6mice. Heterozy-
gous offspring were intercrossed to produce homozygous mutant animals
and their littermate controls. For assessment of their growth capability, preim-
plantation embryos were cultured as described previously (Nishiyama
et al., 2009). All mice in this study were backcrossed to the C57BL/6 back-
ground for more than six generations. Fbxl5+/ mice were also crossed with
Irp2/ mice (LaVaute et al., 2001) obtained from Mutant Mouse Regional
Resource Centers. Fbxl5+/Irp2+/ offspring were intercrossed to produce
Fbxl5/Irp2/ animals and their littermate controls.
Generation of Conditional Knockout Mice
The 50 and 30 regions of homology in the targeting vector for Fbxl5 consisted of
a 1.2 kb fragment of intron 3 and an 8.5 kb fragment spanning introns 3 and 7,
respectively. The neomycin-resistance gene (neo) flanked by loxP sites was
isolated from the plasmid pL2-Neo(2) (kindly provided by D.R. Littman) (Gu
et al., 1993) and inserted upstream of exon 4 of Fbxl5. A loxP site was
also inserted downstream of exon 5. ES clones that had undergone
homologous recombination were transfected with pMC-Cre (kindly provided
by D.R. Littman) to excise the loxP-neo cassette. Mutant ESCs were then
microinjected into C57BL/6 blastocysts, and the resulting chimeras were
mated with C57BL/6 mice. Heterozygous offspring were intercrossed to
produce homozygous mutant animals (Fbxl5F/F). Fbxl5F/F mice were then
crossed with Alb-Cre transgenic mice (Postic and Magnuson, 2000) obtained
from The Jackson Laboratory to produce Alb-Cre/Fbxl5F/F mice. A high-iron
diet was formulated by supplementation of CA-1 (containing 0.03% [w/w]
ferric citrate; CLEA Japan) with 2% (w/w) ferric citrate. All animals were main-350 Cell Metabolism 14, 339–351, September 7, 2011 ª2011 Elsevietained under the specific pathogen-free (SPF) condition, and all experiments
were approved by the animal ethics committee of Kyushu University.
Iron Histochemistry
Mice (pregnant for analysis of embryos) were anesthetized by intravenous
injection of pentobarbital sodium (648mg/kg) and were then perfused consec-
utively with 50 mM hydrogen sulfide in deionized water and with 4% parafor-
maldehyde in phosphate-buffered saline. Iron was detected in cryostat
sections by enhanced Perls or Turnbull staining. Tissue sections were washed
with deionized water, incubated for 30 min with Perls reagent (5% potassium
ferrocyanide, 5% HCl) or with Turnbull reagent (5% potassium ferricyanide,
5% HCl), and then washed again in deionized water before incubation first
for 15 min with unactivated DAB (0.05% DAB in deionized water) and then
for 10 min with activated DAB (0.05% DAB, 1% H2O2). Tissue sections of
control and mutant mice were stained at the same time to allow monitoring
and detection of nonspecific staining.
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridization was performed as described previously
(Nishiyama et al., 2009). An FBXL5 antisense riboprobe corresponding to
nucleotides 396–765 of the cDNA was synthesized with the use of a DIG
RNA labeling kit (Roche).
RT and Real-Time PCR Analysis
RT and real-time PCR analysis was performed as described previously
(Onoyama et al., 2011). Purification of mRNA from embryos was performed
with the use of a TurboCapture mRNA Kit (QIAGEN). The sequences of the
PCR primers (forward and reverse, respectively) were: 50-GGTGATCCATACA
CACCTGGCTT-30 and 50-TGATGACTGAGATGGCGGAA-30 for TfR1; 50-CC
TATCTCCATCAACAGAT-30 and 50-TGCAACAGATACCACACTG-30 for hepci-
din 1 (Hamp1); and 50-GGACCCGAGAAGACCTCCTT-30 and 50-GCACATCAC
TCAGAATTTCAATGG-30 for ARBP (attachment region-binding protein). Reac-
tions for ARBP mRNA were performed concurrently on the same plate as
those for the test mRNAs, and results were normalized by the corresponding
amount of ARBP mRNA.
Immunoblot Analysis
Immunoblot analysis was performed as previously described (Onoyama et al.,
2011) with antibodies to IRP1 (sc-14216; Santa Cruz Biotechnology), to
p150Glued (610473; BD Transduction Laboratories), to phosphorylated
Smad1(Ser463/465)/Smad5(Ser463/465)/Smad8(Ser426/428) (9511; Cell Signaling
Technology), to ferritin (F6136; Sigma-Aldrich), to TfR1 (13-6800; Invitrogen),
to Hsp90 (610419; BD Biosciences), and to IRP2 (generated by K. Iwai, Osaka
University).
Statistical Analysis
Quantitative data are presented asmean ± SEM or ± SD as indicated and were
compared between groups with the two-tailed Student’s t test as performed
with Microsoft Excel software. A p value of <0.05 was considered statistically
significant.
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